CPRX Financial Facts
Loss per share - basic and diluted: -0.05Provision for income taxes: 0
See Full Income Statement
Property and equipment, net: 249.04K
Total liabilities: 2.41M
See Full Balance Sheet
Catalyst Pharmaceutical Partners Inc. (CPRX) Earnings
|
Expand Research on CPRX
| Next EPS Date | 5/7/24 | EPS Growth Rate | -46.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +126.3% | Revenue Growth Rate | +16.4% |
| Average % Move 1-Wk after EPS | -1.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/24  |
Q124 | N/A | $0.22 | N/A | N/A | $99.38M | N/A | N/A | N/A | ||
| 3/16/21 |
 |
Q420 | N/A | $0.09 | N/A | N/A | $30.35M | = | N/A | N/A | |
| 8/9/22 | Q222 | $0.11 | $0.17 | -$0.06 | $33.64M | $49.21M | = |  | | Details | |
| 4/2/12 | Q411 | -$0.10 | -$0.06 | -$0.04 | N/A | N/A | N/A | | | Details | |
| 11/15/12 |
Q312 | -$0.08 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 3/16/20 | |
Q419 | $0.07 | $0.10 | -$0.03 | $30M | $29.4M | = | | | Details |
| 5/16/11 |
Q111 | -$0.08 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 3/18/19 | |
Q418 | -$0.14 | -$0.12 | -$0.02 | N/A | N/A |  |
| | Details |
